“…It also depends on phase 1 and 2 drug-metabolizing enzymes and transporters that exhibit sex differences in expression and activity (Soldin and Mattison, 2009;Soldin et al, 2011;Yang et al, 2012;Franconi and Campesi, 2014a,b) (summarized in Supplemental Table 1). The expression and activity of these enzymes and multidrug resistance protein are regulated by endogenous factors, such as genetics, age, sex, sex hormones, and microbiota, as well as by exogenous factors, such as drugs, diet, and environmental pollutants, which in part act through the nuclear receptors constitutive androstane receptor, pregnane X receptor, and aryl hydrocarbon receptor (AhR) (Smirnova, 2012;Bright et al, 2016). Notably, AhR, constitutive androstane receptor, and pregnane X receptor exhibit sexually biased expression and mode of action (Hernandez et al, 2009;Lu et al, 2013).…”